Sinclair Pharma Announces Mesotherapy Licence Agreement with CircaSkin

Sinclair Pharma Announces Mesotherapy Licence Agreement with CircaSkin
Sinclair Pharma (“Sinclair”, a global aesthetics company headquartered in London and fully-owned subsidiary of Huadong Medicine Company Limited announces the signing of a licence agreement with CircaSkin Ltd, the London based, global aesthetic and skin rejuvenation company, which will result in CircaSkin manufacturing seven mesotherapy products exclusively for Sinclair.

This paves the way for the launch of a new Sinclair Mesotherapy range in the UK and all major European markets during the first half of 2022.

Mesotherapy, is a simple yet highly effective and fast treatment with minimal downtime, designed to create elasticity, improve hydration, and maintain skin tone, and usually administered with a microscopic needle under the surface of the skin. A formulation would typically combine vitamins, minerals, amino acids, hyaluronic acid and antioxidants, and can be used with different modalities depending upon the clinical objective and desired result.

The Sinclair range will target indications to include skin dullness and ageing, hyperpigmentation and sun damage, loss of skin structure and strength, hair thinning, and allow for general rejuvenation and improvements in skin health. Mesotherapy has also been found to be effective when used in combination with energy-based devices (EBDs) and will therefore be complementary with Sinclair’s range of EBDs manufactured under the Cocoon brand name.

Chris Spooner, CEO of Sinclair commented, “We have been looking for a Mesotherapy range for some time to complement our range of fillers, collagen stimulators and EBDs. I am delighted to be teaming up with CircaSkin who have a track record of producing highly successful and efficacious mesotherapy solutions”.

Claire Williams, CEO of CircaSkin added; “With a consultative approach to marketing, training, sales, and customer services we seek partnerships with like-minded organisations from around the world to help us strive for excellence in the aesthetic field. Sinclair fits this objective perfectly and we are very excited about this new collaboration”

About Huadong Medicine Company Limited

HMC is a manufacturer and distributor of pharmaceutical and medical products in China, where it has over 10,000 employees and generated approximately $5.4 billion of revenue in the financial year ended 31 December 2019. Over the past five years, HMC has established a leading aesthetics business in China, offering a toxin and a variety of fillers. HMC is an affiliate of China Grand Enterprise Inc. (CGE), an investment group headquartered in Beijing. CGE has four business sectors: pharmaceuticals and healthcare, commodities trading, real estate investment and financial services, among which, pharmaceuticals and healthcare sector is the core business. CGE is ranked in the top five enterprises
in the Chinese Pharmaceutical industry and manages over 60 pharmaceutical subsidiary companies, HMC is the largest one.

About Sinclair Pharma

Sinclair Pharma is an international company operating in the fast growth, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. Sinclair is planning entry to multiple new geographic markets and line extension launches over the next few years. The Group has an established sales and marketing presence in the EU markets, Brazil, US, Mexico, UAE, Russia and South Korea and a network of international distributors.

For more information, visit

About CircaSkin

Circa Skin Ltd. is a London based global distribution company, specialising in sourcing aesthetic & skin rejuvenation solutions & bringing advanced & innovative brands to the market.

For more information visit

Media Contacts:
Sinclair Pharma
Tel: +44 (0) 20 7467 6920
Chris Spooner
Andy Crane

Share this post:

Sinclair Network

At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.

Sinclair Pharma News

Industry News

Sinclair Pharma and Tamer Group KSA announce exciting new partnership in the Middle East

Sinclair Pharmaceuticals Ltds. is delighted to announce its latest partnership in the Middle East with Tamer Group KSA, as its exclusive distributor in Saudi Arabia. Tamer Group is a leading healthcare, beauty care, prestige products, fast-moving consumer goods, and logistics company serving communities throughout the Middle East. We believe this new prestigious partnership with Tamer Group will be servicing the needs within the aesthetics sector of Saudi Arabia with the highest standards and ethics.